Getting a Handle on Neuropharmacology by Targeting Receptor-Associated Proteins.

Maher, Michael P; Matta, Jose A; Gu, Shenyan; Seierstad, Mark; Bredt, David S

Maher, Michael P; Matta, Jose A; Gu, Shenyan; Seierstad, Mark; Bredt, David S.

Afiliação

Maher MP; Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, USA.
Matta JA; Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, USA.
Gu S; Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, USA.
Seierstad M; Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, USA.
Bredt DS; Neuroscience Discovery, Janssen Pharmaceutical Companies of Johnson & Johnson, 3210 Merryfield Row, San Diego, CA 92121, USA. Electronic address: dbredt@its.jnj.com.

Neuron ; 96(5): 989-1001, 2017 Dec 06.

Article em En | MEDLINE | ID: mdl-29216460

Assuntos

Neurofarmacologia; Receptores de Neurotransmissores/efeitos dos fármacos; Animais; Humanos; Proteínas do Tecido Nervoso/efeitos dos fármacos

Palavras-chave

AMPA receptor; GABA receptor; NMDA receptor; accessory protein; acetylcholine receptor; auxiliary subunit; drug discovery; kainite receptor; ligand-gated ion channel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofarmacologia / Receptores de Neurotransmissores Tipo de estudo: Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google